What does CUSIP 92243G108 represent in this 13F holders report?

CUSIP 92243G108 is the security identifier for PCVX - Vaxcyte, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PCVX - Vaxcyte, Inc. - Common Stock in Q1 2026?

336 institutional investors reported PCVX - Vaxcyte, Inc. - Common Stock for Q1 2026. Use the holders table for investor-level position and value details.

Vaxcyte, Inc. - Common Stock (PCVX)

CUSIP: 92243G108

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock
Total 13F shares: 162,526,146
Total 13F value: $9,435,712,046
Share change: +12,752,215
Put/Call ratio: 165%
SEC-reported price per share: $58.11
Number of holders: 336
Value change: +$770,395,667
Number of buys: 190
Number of sells: 106
Shares outstanding: 149,094,008

Security key

92243G108

Report period

Q1 2026

Institutions

336

Top holders

PCVX full security history Ownership snapshot Full 13F holder table Vaxcyte, Inc. SEC filings Vaxcyte, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PCVX - Vaxcyte, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

31 Mar 2026

13D/G 13F Lead comparable stake: 8.9% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 8.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 8.9%

T. Rowe Price Investment Manageme... 8.6%

BlackRock, Inc. 7.6%

VANGUARD CAPITAL MANAGEMENT LLC 5%

FMR LLC 9.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13D/G 13F Company 13D/G 13F	8.9%	$801,181,488 12,974,599 shares	+$624,169	31 Mar 2026
T. Rowe Price Investment Management, Inc.	13F 13D/G Company 13F 13D/G	8.6% from 13D/G	$521,213,000 11,296,333 shares	—	31 Dec 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	7.6% from 13D/G	$472,767,877 10,246,378 shares	—	31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC	13D/G Vanguard Capital Management 13D/G	5%	$421,416,800 7,252,053 shares	$0	31 Mar 2026
FMR LLC	13F Company 13F	9.3%	$638,324,485 13,834,514 shares	—	31 Dec 2025
Janus Henderson Group Ltd.	13F Company 13F	9%	$617,730,753 13,387,188 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

336

162,526,146

Rows available

336

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

336

Q1 2026 holders

336

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %